Navigation Links
United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension
Date:9/20/2012

SILVER SPRING, Md., Sept. 20, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has signed an exclusive agreement with Ascendis Pharma A/S to apply Ascendis Pharma's proprietary TransCon technology platform to United Therapeutics' treprostinil molecule, the active ingredient in Remodulin® (treprostinil) injection.  United Therapeutics believes that the TransCon technology platform may enable a controlled, long-acting release of a novel, carrier-linked product, significantly enhancing the delivery profile of treprostinil by establishing a self-injectable alternative for patients who currently use the drug via a continuous infusion pump for the treatment of pulmonary arterial hypertension (PAH).

"We are thrilled to enter into this license agreement with Ascendis Pharma," said Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer.  "The potential to bring another novel therapeutic option to PAH patients represents an exciting new opportunity for Remodulin delivery as we constantly re-charge our mission to better the lives of patients suffering from PAH."

"Pre-clinical studies in multiple animal models with a lead compound of TransCon-linked treprostinil have already produced encouraging results, demonstrating a sustained release profile supportive of once-daily injection.  The application of TransCon technology to treprostinil may also minimize injection site pain and reactions that frequently occur with continuously infused subcutaneous Remodulin," commented Roger Jeffs, Ph.D., United Therapeutics' President and Chief Operating Officer.  "We are very excited to be working with Ascendis Pharma to further develop and advance this promising product into the clinic."

Under the terms of the agreement, United Therapeutics will also have exclusive rights to develop prostacycl
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. United Seating & Mobility Completes Acquisition of Glass Seating & Mobility
2. Philips and Corindus announce distribution agreement to sell Corindus robotic-assisted interventional cardiology system in the United States
3. Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers
4. United Spinal Appointed to U.S. Access Board: Developing Accessible Standards for Medical Diagnostic Equipment
5. Alternate Distribution Channels Claim Opportunities for OTC Drug Sales in the United States, Finds Kline
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
8. United Seating & Mobility Completes Acquisition of Active American Mobility
9. Celladon Corporation Receives Patent from United States Patent and Trademark Office
10. 2012 United States Medical Devices Outlook
11. United States Market for Psoriatic Arthritis Pharmacotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 The Cadence Fitness & Health ... by the Medical Fitness Association, a non-profit organization assisting ... full potential. The Cadence Fitness & Health Center is ... and second in the Chicagoland area. "The ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
(Date:7/9/2014)... Cincinnati, OH, July 10, 2014 -- The World Health ... 60 minutes of moderate to vigorous physical activity (MVPA) ... most of their MVPA during school hours. Therefore, ... school hours would increase MVPA. In a new ... Pediatrics , researchers confirmed that time spent outdoors after ...
(Date:7/9/2014)... For the first time, researchers have access to detailed ... uses health care. A new study, called Our Health ... unique challenges faced by urban Aboriginal people in Canada ... , The findings, published today in BMJ Open ... and the general population. , Researchers interviewed 554 First ...
(Date:7/9/2014)... (PHILADELPHIA) Researchers at the Perelman School of Medicine ... Roswell Park Cancer Institute have received an $8 million ... the effects of photodynamic light therapy (PDT) in patients ... cancer that most often manifests itself in the lining ... exposure to asbestos. The grant will fund a clinical ...
(Date:7/9/2014)... types of cancer sends the protein factories in our ... uncontrolled growth, new research suggests. , Scientists at The ... responsible for ratcheting up activity of the endoplasmic reticulum ... blocks cancer cells need to keep growing. , A ... the flow of messages to the endoplasmic reticulum telling ...
(Date:7/9/2014)... cancer, researchers have uncovered mutations in a cell-signaling pathway ... knowledge may expand treatments for patients because drugs targeting ... are in clinical trials. , Reporting July 9 in ... (TCGA), including researchers at Washington University School of Medicine ... studied tumors from 230 patients with lung adenocarcinoma. , ...
Breaking Medicine News(10 mins):Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Urban Aboriginal people face unique health challenges 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Lung cancer study hints at new treatments 2
... A new Institute of Medicine report specifies the types ... require before allowing tobacco companies to sell or advertise ... the health risks of tobacco use. While modified ... comprehensive strategy to lower tobacco-related death and disease in ...
... 10th and 12th-graders are at their lowest point since ... in 1975, according to this year,s survey results. However, ... of decline in teen smoking as well as continued ... hookahs, small cigars, smokeless tobacco), marijuana and prescription drugs. ...
... is available in German . Next ... have been announced: The Joint Committee of the Deutsche Forschungsgemeinschaft ... two women and nine men as winners of ... nominations committee from 131 nominations. Five of the award winners ...
... its ongoing efforts to ensure safe, effective and appropriate ... the ABIM Foundation and eight other medical specialty societies ... by physicians and patients to improve health outcomes, avoid ... The ACR will develop a list of ...
... a new mechanism that could potentially explain why the body,s ... shed light on the possible cause of immune resistance in ... low-cost drug used for more than a century to treat ... "This discovery may lead to new approaches for the treatment ...
... Queensland University of Technology (QUT) PhD student has developed ... the spread or return of breast cancer. , ... in the treatment of breast cancer there has been ... a PhD student at the Institute of Health and ...
Cached Medicine News:Health News:New report identifies research needed on 'modified risk' tobacco products 2Health News:New report identifies research needed on 'modified risk' tobacco products 3Health News:Cigarette and alcohol use at historic low among teens 2Health News:Cigarette and alcohol use at historic low among teens 3Health News:Cigarette and alcohol use at historic low among teens 4Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 2Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 3Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 4Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 5Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 6Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 7Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 8Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 9Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 10Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 11Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 12Health News:ACR in Choosing Wisely campaign to promote wise use of resources among physicians and patients 2Health News:Heart drug may be effective for managing certain cancers: Queen's University study 2Health News:New test to indicate likely spread or recurrence of breast cancer 2
The incorporation of a reverse osmosis (RO) system and an ultrapure water system into a single stand-alone tower provides numerous benefits to the busy laboratory....
... systems produce ultrapure water from pre-treated water at ... to meet the basic needs of scientific laboratories. ... lamp (185 nm and 254 nm) to produce ... 5 ppb TOC when fed by Elix water). ...
... speed, stability and durability. Back-lighted Display. ... multiple units of measure, piece counting ... and GLP/GMP/ISO output including date and ... Built-in, motor-driven internal calibration mass for ...
... UniBloc weighing mechanism for speed, stability ... control, analog display modes, multiple units ... measure functions, auto print, and GLP/GMP/ISO ... from built-in clock. Built-in, motor-driven ...
Medicine Products: